Finanzas de Align Technology, Inc. (ALGN)ALGNAlign Technology, Inc.

Align Technology, Inc. (ALGN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Clear Aligner, accounting for 79.5% of total sales, equivalent to $804.62M. Another important revenue stream is Systems and Services. Understanding this composition is critical for investors evaluating how ALGN navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Align Technology, Inc. maintains a gross margin of 72.82%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.42%, while the net margin is 10.25%. These profitability ratios, combined with a Return on Equity (ROE) of 10.16%, provide a clear picture of how effectively ALGN converts its operational activities into shareholder value.

In the context of the broader market, ALGN competes directly with industry leaders such as GMED and COO. With a market capitalization of $10.89B, it holds a significant position in the sector. When comparing efficiency, ALGN's gross margin of 72.82% stands against GMED's 65.68% and COO's 63.05%. Such benchmarking helps identify whether Align Technology, Inc. is trading at a premium or discount relative to its financial performance.

Align Technology has a forward P/E of 11.67 and a gross margin of 72.82% in Q2 2026, reflecting strong profitability. However, the company has seen a decline in net income in recent quarters, with a notable drop in Q3 2025 to $56.75 million, raising concerns about future earnings stability.